Drug Markets/Tirzepatide

Tirzepatide

12 NDCs across 1 manufacturer|0 Generic,12 Brand

Tirzepatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 13, 2022. In 2024, Medicare Part D spent $6.3 billion on Tirzepatide across 5.1 million claims for 895,000 beneficiaries.

Tirzepatide is available as 12 NDCs from 1 manufacturer (0 generic, 12 brand), with NADAC prices from $525.59 to $538.83 per ML — a 3% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

12

0G / 12B

Manufacturers

1

competing in market

Price Spread

$525.59 – $538.83

per ML

7d Activity

12↑10↓-12 flat

avg -0.0% WoW · of 12 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing TIRZEPATIDE

Drug Portfolio

12 NDCs total, 12 shown

WatchDrug ↕Price 7d Change ↕
MOUNJARO 10 MG/0.5 ML PEN
$538.8259
per ML
+0.01%
MOUNJARO 2.5 MG/0.5 ML PEN
$538.8104
per ML
+0.01%
MOUNJARO 7.5 MG/0.5 ML PEN
$538.8009
per ML
+0.01%
MOUNJARO 5 MG/0.5 ML PEN
$538.7628
per ML
+0.01%
MOUNJARO 12.5 MG/0.5 ML PEN
$538.6401
per ML
+0.01%
MOUNJARO 15 MG/0.5 ML PEN
$538.6287
per ML
+0.01%
ZEPBOUND 2.5 MG/0.5 ML PEN
$526.2183
per ML
0.00%
ZEPBOUND 7.5 MG/0.5 ML PEN
$525.8177
per ML
-0.04%
ZEPBOUND 5 MG/0.5 ML PEN
$525.8145
per ML
-0.05%
ZEPBOUND 10 MG/0.5 ML PEN
$525.7493
per ML
-0.06%
ZEPBOUND 15 MG/0.5 ML PEN
$525.6651
per ML
-0.05%
ZEPBOUND 12.5 MG/0.5 ML PEN
$525.5938
per ML
-0.05%

Frequently Asked Questions

What is Tirzepatide used to treat?

Tirzepatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Tirzepatide?

In 2024, Medicare Part D spent $6.3 billion on Tirzepatide across 5.1 million claims for 895,000 beneficiaries.

How many Tirzepatide products are on the market?

The Tirzepatide drug market contains 12 NDCs from 1 manufacturer — 0 generic and 12 brand products.

What is the price range for Tirzepatide?

NADAC reference prices for Tirzepatide range from $525.5938 to $538.8259 per ML — a 3% difference between cheapest and most expensive.

Which manufacturers make Tirzepatide?

1 manufacturer lists Tirzepatide in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (12).

How has the price of Tirzepatide changed recently?

Over the past 7 days, 12 Tirzepatide NDCs rose and 10 fell, with a market-wide average change of -0.0%.